Clinical trial
Study to Evaluate the Efficacy, Safety, and Tolerability of E7070 in Metastatic…
NCT00080197 · Eisai Inc., Industry · Completed
Key facts
| NCT number | NCT00080197 |
|---|---|
| Title | Study to Evaluate the Efficacy, Safety, and Tolerability of E7070 in Metastatic Breast Cancer Patients |
| Official title | An Open-Label Phase II Study of E7070 in Metastatic Breast Cancer Patients Previously Treated With an Anthracycline, a Taxane, and Capecitabine |
| Lead sponsor | Eisai Inc., Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Neoplasms, Metastases |
| Intervention type | Drug |
| Interventions | E7070 |
| Enrollment | 250 |
| Start date | Feb 1, 2004 |
| Completion | May 1, 2005 |
| First posted | Mar 25, 2004 |
| Last update posted | Oct 11, 2006 |
| Countries | Canada, United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: